Arquer Diagnostics
is a UK-based company committed to manufacturing
and marketing innovative, non-invasive
cancer tests for diagnosis and monitoring
VISION
Inspiring transformational change in the
field of oncology diagnostics
MISSION
To develop and deliver accurate, rapid, minimally
invasive oncology diagnostic products utilising our
patented MCM5 antibodies
Our tests use patented technology to detect the presence of a protein produced by the expression of the MCM5 (Minichromosome Maintenance Complex Component 5) gene.
Our accurate and reliable tests meet the demands of patients, clinicians and payers for non-invasive, pain-free, healthcare technologies which not only improve patient care but reduce healthcare costs.
ADXBLADDER is the first of Arquer’s MCM5 tests to be released as a CE marked bladder cancer test and we are also currently testing the technology in prostate and endometrial cancers.
Latest News
A MESSAGE
FOR PATIENTS
ADXBLADDER is only available via a Urologist. Please contact yours to discuss its availability in your local NHS hospital, or privately.
If you are not under a Urologist’s care then please talk to your GP for a referral.
Alternatively you can
contact us here.